UBTECH ROBOTICS (09880.HK): Files CSRC Filing for H-share Full Circulation; 17.6m Shares to Convert
NewTimeSpace News: On 23 September 2026, UBTECH Robotics Corp Ltd (the "Company") announced, pursuant to Rule 13.09(2)(a) of the Hong Kong Listing Rules and the inside information provisions, that the board has approved the proposed conversion of 17,581,288 unlisted domestic shares held by certain shareholders of the Company into H shares to implement H-share Full Circulation, representing approximately 3.49% of the Company's total issued share capital as of the date of this announcement.
The announcement disclosed that on 23 September 2026, the Company submitted a filing application to the China Securities Regulatory Commission (the "CSRC") for the implementation of the H-share Full Circulation. Upon completion of all relevant regulatory procedures (including the CSRC's filing notice and the Stock Exchange's approval) and compliance with all applicable laws and regulations, the 17,581,288 domestic shares will be converted into H shares, and the Company will apply to the Stock Exchange for approval of the listing and trading of such H shares on the Main Board.
The Company stated that under its articles of association, it is not required to convene a shareholders' meeting to approve the H-share Full Circulation; as of the date of this announcement, the details of the implementation plan have not yet been finalised and the Company has not completed the CSRC filing procedure. The Company will make further announcements on the progress in accordance with the inside information provisions and/or the Listing Rules, and reminds shareholders and intending investors to exercise caution when dealing in the Company's shares.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- TIAN TU CAPITAL (01973.HK): Disclosed Transaction — Invests US$25m in Topos AI Infrastructure
- WAN KEI GROUP (01718.HK): Further Reallocates 2016 Placing Proceeds; HKD 3.4mn to Working Capital
- SUNSHINE PHARMA (06887.HK): Files CSRC Filing for H-share Full Circulation; 38.9m Domestic Shares to Convert
- JINYUAN HCHEM (02502.HK): H1 Revenue RMB 1.54bn, Up 7.0%; Profit RMB 41.6mn Turns to Profit
- GENCH EDU (01525.HK): Independent Non-exec Director Changes; Shi & Zhang Appointed, Chen & Liu Resigned